Poly(A) RT-PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer.
BACKGROUND
The last decade has seen significant progress in understanding the molecular biology of pancreatic adenocarcinoma. There is now an urgent need to translate these molecular techniques to clinical practice in order to improve diagnosis and prediction of response to treatment. The objectives of this study are to utilise poly(A) RT-PCR to measure expression levels of diagnostic Indicator genes, selected from microarray studies, of RNA from intraoperatively sampled pancreatic ductal juice and to correlate these expression levels with those in matched pancreatic tissue resection samples.


METHODS
Intraoperative sampling of pancreatic juice and collection of matched tissue samples was undertaken in patients undergoing pancreaticoduodenectomy for suspected tumour. RNA was isolated and poly(A) PCR and real-time PCR used to measure expression levels of 30 genes. Spearman's rank correlation test was used to examine the relationship of gene expression between pancreatic juice and tissue.


RESULTS
Of the 30 Indicator genes measured, just one, ANXA1, showed a significant correlation of expression level between pancreatic juice and tissue samples, whereas three genes, IGFBP3 (P0.035), PSCA (P0.001) and SPINK1 (P0.05), showed significantly different expression between cancerous and benign pancreatic tissue samples.


CONCLUSIONS
These results demonstrate that RNA analysis of pancreatic juice is feasible using the poly(A) cDNA technique, that correlation of gene expression exists between pancreatic juice and tissue for very few genes and that gene expression profiling can distinguish between benign and malignant pancreatic tissue. This indicates possible use of the technique for measurement of Indicator genes in pancreatic tissue for diagnosis of pancreatic cancer from very small tissue samples.
Hepatobiliary Surgery Unit, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
M
M
Oliveira-Cunha
R J
RJ
Byers
A K
AK
Siriwardena
D000230:Adenocarcinoma / Q000235:genetics*; D020869:Gene Expression Profiling; D006801:Humans; D046228:Microarray Analysis; D010189:Pancreatic Juice / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000601:surgery; D016577:Pancreaticoduodenectomy; D011061:Poly A / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D011061:Poly A
Pancreas. 2010 Mar;39(2):171-4
19940796
Ann Surg Oncol. 2006 Dec;13(12):1645-54
16957968
Methods Mol Biol. 2010;630:13-32
20300988
Cancer Biol Ther. 2006 Oct;5(10):1390-1
17172808
Int J Cancer. 2004 Oct 20;112(1):100-12
15305381
Cancer Res. 2002 May 15;62(10):2890-6
12019169
Pancreas. 2007 Jul;35(1):98-100
17575552
World J Gastroenterol. 2006 Jun 7;12(21):3344-51
16733850
Cancer Res. 2003 Dec 15;63(24):8614-22
14695172
Lancet. 2001 Nov 10;358(9293):1576-85
11716884
Cancer Res. 2001 Jun 1;61(11):4320-4
11389052
Mol Cell Probes. 2005 Apr;19(2):101-9
15680211
Am J Pathol. 2002 Apr;160(4):1239-49
11943709
Blood. 2008 May 1;111(9):4764-70
18174380
Am J Pathol. 2003 Apr;162(4):1151-62
12651607
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6152-8
15448002
Cancer Res. 2002 Feb 1;62(3):819-26
11830538
Mod Pathol. 2005 Jun;18(6):779-87
15791284
Endocrinol Metab Clin North Am. 2006 Jun;35(2):333-43, ix
16632096
Neoplasia. 2004 Sep-Oct;6(5):611-22
15548371
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
19474385
Ann Surg. 2001 Dec;234(6):769-78; discussion 778-9
11729383
Biotechnol J. 2008 Jan;3(1):112-23
18074404
Crit Rev Clin Lab Sci. 2006;43(2):103-42
16517420
Lancet. 2004 Apr 24;363(9418):1346-53
15110491
Methods. 2001 Dec;25(4):402-8
11846609
World J Gastroenterol. 2004 May 15;10(10):1466-70
15133855
J Mol Med (Berl). 2006 Nov;84(11):901-10
16972087
Curr Biol. 1995 Aug 1;5(8):909-22
7583149
Methods Enzymol. 1993;225:611-23
8231874
Br J Haematol. 2005 Jul;130(2):233-48
16029452
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1735-40
9465086
Cancer Res. 2003 May 15;63(10):2649-57
12750293